Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial

Authors

Institutions

Publication Details

Journal
The Lancet
Published
2025-11-01
DOI
https://doi.org/10.1016/s0140-6736(25)01726-x
Citations
1
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial

John A. Todd, An Jacobs, Mariusz Ołtarzewski, Kristina Casteels et al.
1 citations
The Lancet
Diabetes and associated disorders
1.82
article

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial

John A. Todd, An Jacobs, Mariusz Ołtarzewski, Kristina Casteels, Olga Kordonouri, Christiane Winkler, Ezio E. Bonifacio, Peter Achenbach, Reinhard Berner, Matthew D. Snape, Thekla von dem Berge, Florian Haupt, Manu Vatish, Anette‐Gabriele Ziegler, Andreas Weiß, Helena Elding Larsson, Markus Pfirrmann, Agnieszka Szypowska, Markus Lundgren, Angela Hommel
article en
1 citations

Abstract

No abstract available for this paper.
The LancetVol. 406(10519)
Medical University of Warsaw (PL), Universitair Ziekenhuis Leuven (BE), John Radcliffe Hospital (GB), Helmholtz Zentrum München (DE), University of Oxford (GB), Kinderkrankenhaus auf der Bult (DE), Zimmer Biomet (Germany) (DE), Skåne University Hospital (SE), Oxford BioMedica (United Kingdom) (GB), Deutsches Diabetes-Zentrum e.V. (DE), German Center for Diabetes Research (DE), University Hospital Carl Gustav Carus (DE), Paul Langerhans Institute Dresden (DE), Heinrich Heine University Düsseldorf (DE), Technische Universität Dresden (DE), Ludwig-Maximilians-Universität München (DE), KU Leuven (BE)
Eli Lilly and Company, Leona M. and Harry B. Helmsley Charitable Trust, Universität Basel, Integrated BioBank of Luxembourg, Imperial College London, University of Oxford, University of Bristol, Bundesministerium für Bildung und Forschung, Technische Universität München, Novo Nordisk Fonden
Openalex Percentile: Top 11%
Diabetes and associated disorders
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.